Table 1.
Characteristics of Patients with Lymphocytic Colitis
| Patients | Age, yr | Sex | Symptom | Symptom frequency (per day) | Symptom duration (wk) | Concomitant drugs (duration, mo) | Concurrent disease | Treatment | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| PPI | Aspirin | NSAIDs | Statin | BSP | Ticlopidine | ||||||||
| Patients without mucosal lesions | |||||||||||||
| 1 | 77 | M | Diarrhea | 4 | 4 | O (48) | HLD | 5-ASA | |||||
| 2 | 25 | F | Diarrhea | 3 | 12 | None | 5-ASA | ||||||
| 3 | 66 | F | Diarrhea | 5 | 4 | Thyroiditis | None | ||||||
| 4 | 64 | F | Diarrhea | 2 | 48 | O (4) | O (24) | HLD, HL | 5-ASA | ||||
| 5 | 68 | F | Diarrhea | 3 | 4 | None | None | ||||||
| 6 | 76 | F | Diarrhea | 5 | 4 | O (48) | O (24) | HTN, OA, HL | 5-ASA | ||||
| 7 | 51 | M | Diarrhea | 3 | 8 | TB | None | ||||||
| Patients with mucosal lesions | |||||||||||||
| 8 | 75 | M | Diarrhea | 20 | 12 | LPZ (12) | DM, GERD | Steroid | |||||
| 9 | 63 | M | Diarrhea | 20 | 5 | LPZ (8) | O (2) | DM, HTN, GERD | Steroid | ||||
| 10 | 55 | F | Diarrhea | 10 | 12 | None | 5-ASA | ||||||
| 11 | 77 | F | Diarrhea | 7 | 8 | O (12) | HTN | None | |||||
| 12 | 74 | F | Diarrhea | 10 | 8 | None | Steroid | ||||||
| 13 | 78 | F | Diarrhea | 5 | 8 | LPZ (4) | O (20) | O (20) | O (20) | HTN, GERD | None | ||
| 14 | 72 | F | Diarrhea | 6 | 8 | O (2) | OA | 5-ASA | |||||
PPI, proton pump inhibitor; NSAIDs, nonsteroidal anti-inflammatory drugs; BSP, bisphosphonate; M, male; HLD, herniated lumbar disc; 5-ASA, 5-aminosalicylic acid; F, female; HL, hyperlipidemia; HTN, hypertension; OA, osteoarthritis; TB, pulmonary tuberculosis; LPZ, lansoprazole; DM, diabetes mellitus; GERD, gastroesophageal reflux disease.